Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Maintain ADD on L&T Technology Services - Enduring the ebbs and flows - HDFC Securities

Posted On: 2020-05-18 11:58:40


Mr. Apurva Prasad & Mr. Amit Chandra, Institutional Research Analyst, HDFC Securities.

L&T Technology Services (Q4FY20): Enduring the ebbs and flows. Maintain ADD
(TP Rs 1,125, CMP Rs 1,068, MCap Rs 111bn)

Maintain ADD on L&T Technology Services (LTTS) with in-line operating performance and lower rev in 4Q. While weaker cash conversion and high susceptibility to deferral in discretionary projects are negatives, (1) Leadership within ER&D segment (consolidation opportunities), (2) Recovery in deal pipeline to pre-COVID levels, and (3) Diversified client & vertical base mitigating the volume compression in high-impact verticals are positives. Our TP of Rs 1,125, at 14x FY22E EPS (~7% cut in EPS).

Short term growth trajectory impact, offset by uptick in deal pipeline: LTTS posted revenue of USD 195.4mn, -1.1/+3.4% QoQ/YoY CC impacted by steep decline in the Plant Engineering vertical (Oil & Gas sub-segment) on account of abrupt project closure and softness in Transportation vertical. Delay in project ramp-up and deferral in long-tenured projects are likely to impact the short term trajectory, despite an uptick in deal pipeline to pre-COVID levels. Deal wins in Apr/May period can support recovery beyond the 1Q decline, apart from ramp-up of strong wins from 4Q (USD 30mn+ TCV deal and 3 deals in USD 10-20mn TCV range). FY20 revenue growth was 9.3% CC.

Near term outperformance of Telecom & Hi-tech and Medical verticals: Telecom & Hi-tech vertical and Medical devices vertical are expected to outperform in the near-term based on relative resilience (semiconductor/M&E strength) and deal wins in the segments (4 in Telecom & Hi-tech). Plant engineering is expected to languish longer with continued impact in its Oil & Gas sub-segment (volume/budget cuts), partly offset by its CPG/Specialty chemicals sub-segments.

Revenue-mix shift and operating de-leverage headwinds to margin: EBIT margin stood at 15.2%, -161bps QoQ (16.5% adj. for one-time CSR component of Rs 0.18bn). Shift towards lower-margin Telecom & Hi-tech and decline in revenue are margin headwinds. PAT was supported by higher other income led by forex gain and export license incentive. Cash generation deteriorated in FY20 (21% drop in OCF in FY20) with increase in DSO from 76 days in FY19 to 90 days in FY20 and increase in unbilled revenue.

Valuation and view: We've factored USD rev/APAT decline of 4.3/8.1% with margin decline of 100bps, with growth divergence across segments Plant Engg./Medical Devices growth at -16/+23% in FY21. Subsequent recovery in rev growth at 11.5% and operating margin reverting back to FY20-levels is built-in for FY22. At CMP, LTTS trades at 16.2/13.3x FY21/22E at a discount to its historical avg. of 19x. While a diversified vertical portfolio is a key differentiator, the broad-based economic impact dilutes the moat (higher impact in Plant engineering, Industrial and Transportation).

Shares of L&T Technology Services Ltd was last trading in BSE at Rs.1069.9 as compared to the previous close of Rs. 1114.65. The total number of shares traded during the day was 10959 in over 2654 trades.

The stock hit an intraday high of Rs. 1123 and intraday low of 1066.45. The net turnover during the day was Rs. 11876859.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities

Solar Industries - Overseas and defence key to profitability - ICICI Securities

Federal Bank - Strengthening liability muscle; fees & charges revised upwards - ICICI Securities

HCL Technologies Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd

CAMS - IPO Note - YES SECURITIES

I-direct Instinct - Intellect Design Arena

P&G Health - Company Update - ICICI Securities

Relaxo Footwears - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Bata India - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Listing of Happiest Minds Technologies - Angel Broking

Dr. Reddy's Lab - Sep 17, 2020 - Angel Broking

VA Tech Wabag - Uphill task ahead; dilution at discount valuation - ICICI Securities

Polymer price tracker - PVC price hikes continue unabated - ICICI Securities

Brigade Enterprises - Resilience amid turbulence - ICICI Securities

Apollo Hospitals Enterprises - Recovering well from COVID-19 impact - ICICI Securities

NTPC - Sustainability targets encouraging - ICICI Securities

Gladiator Stocks - Oberoi Realty - ICICI Securities

Gladiator Stocks - Automotive Axles - ICICI Securities

Quant Pick - IDFC First Bank - ICICI Securities

Company Update - Jammu & Kashmir Bank - ICICI Securities

India Aviation Data - August 2020 - Angel Broking

Shree Cement - Higher volumes to offset lower prices - ICICI Securities

Apollo Hospitals - Q1FY21 Result Update - ICICI Securities

Refining & marketing - Oil price fall boosted GRMs, to push marketing margins up - ICICI Securities

Mr. Deepak Jasani, Head of Retail Research views on FICCI National Executive Committee Meeting with Reserve Bank of India Governor Shaktikanta Das

India trade deficit for August 2020 - Angel Broking

Chemcon Chemicals IPO - Mr. Keshav Lahoti - Associate Equity Analyst, Angel Broking Ltd

CAMS IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

August 2020 Trade Data - Acuité Ratings & Research

Wim Plast - Q1FY21 Result Update - ICICI Securities

Company Update - Mishra Dhatu Nigam - ICICI Securities

Stock Tales - Laurus Labs - ICICI Securities

Stock Tales - Granules India - ICICI Securities

Stock of the day - Chalet Hotel - Target INR 200 - Angel Broking

Upgrade to ADD on Dr. Reddy's Labs - Improved visibility in the US business - HDFC Securities

Monetary Policy post CPI inflation numbers for August 2020 - Angel Broking

HUDCO - Q1FY21 Result Update - Angel Broking

Update on Steriscience pharma - Angel Broking

Covid-19 vaccine development by AstraZeneca - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019